New Covid Variant PJ.2.1 Spreads Globally: Symptoms, Risks And Key Facts

A new COVID-19 variant, PJ.2.1, is spreading across North America and other regions after being identified in Canada. While the variant features significant mutations, researchers state there is currently no evidence it causes more severe illness than previous strains.
Why it matters
Monitoring new variants is essential for public health preparedness and understanding the ongoing evolution of the SARS-CoV-2 virus.
A new COVID-19 variant , PJ.2.1, is attracting attention as it spreads across North America and other parts of the world. First identified in Ontario, Canada, in May 2026 , the emerging SARS-CoV-2 lineage has subsequently been detected in the United States, Europe, Australia, New Zealand and parts of Asia. Its spread has raised questions about whether it could trigger another wave of infections and whether existing immunity offers sufficient protection. The variant has a highly mutated spike protein, the part of the coronavirus that helps it enter human cells. However, preliminary research published in the Journal of Infection suggests that its growth may be linked more closely to increased binding to the ACE2 receptor than to a substantial ability to evade vaccine-induced antibodies.
Also covering this story
One other newsroom covered this event. We read that version too.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in